Entirely online and in English, applications are open until September 4

LISBON, Portugal, July 23, 2024 /PRNewswire/ -- The Faculty of Pharmacy of the University of Lisbon, in Portugal, has just launched the 2nd edition of the Postgraduate course on Access to the International Pharmaceutical Market.

This course is aimed at professionals with and without experience in market access, with experience in economics, marketing or health sciences. It was designed to enhance and increase skills and understanding of Market Access and developed in response to the industry's need for specialized training, aiming to equip professionals with the skills needed to excel in this area. Two former students from the Faculty of Pharmacy, Ana Filipa Alexandre and Alexandre Baptista, together with Professor Beatriz Lima and Professor Hélder Mota Filipe, collaborated to bring this course to life, sharing their vast experience and knowledge.

Today, market access is an increasingly complex, time-consuming and challenging process for professionals who have to manage negotiations for the entry and reimbursement of medicines on the market. The curriculum of this postgraduate course provides students with tools to help define and execute effective access strategies from the earliest stages of product development, as well as navigating various access systems. This course covers the main markets, such as Germany, France, the United Kingdom, the United States, Japan, among others, which are essential for a successful global drug reimbursement strategy.

The International Market Access course offers a unique opportunity to learn from key global opinion leaders in the pharmaceutical industry, EMA, national HTA agencies, top consulting firms and academia.

Beatriz Silva Lima, Director of the Faculty of Pharmacy in Lisbon, explains that "the main objective of this course is to train professionals in the different components that are necessary to enable a medicine, once approved, to be able to access the market".

The course will run from September 14, 2024, to January 25, 2025, with a total of 72 hours of training, entirely online and in English.

Applications are open until September 4 (here) and for more information visit our website or contact us at cncg@ff.ulisboa.pt.

The coordination team includes:

Ana Filipa Alexandre: Market Access and Health Economics and Outcomes Research (HEOR) strategist at both Global and Regional levels
Alexandre Baptista: Expert Consultant in Real World Evidence (RWE), HEOR and Market Access
Beatriz Silva Lima: Director of the Faculty of Pharmacy of Lisbon (FFUL), Former Expert in Nonclinical Development Science at EMA
Hélder Mota Filipe: Associate Professor of FFUL, President of the Portuguese Pharmacists Association and Former President of INFARMED the Portuguese Agency for Medicines

Logo -

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/portuguese-faculty-of-pharmacy-launches-2nd-edition-of-international-market-access-postgraduate-course-302202891.html

Images

Tags

More Like This

2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries

A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies' access efforts are

Sanofi: Poland's EU Presidency - Paving the Way for a Competitive Pharmaceutical Industry

Portugal National Funder FCT Agrees Transformative Agreement with Elsevier

2024 International Pharmaceutical Cooperation High-End Forum Kexing Biopharm's Series of Globalization Activities (China) Successfully Concluded

PRODUCTLIFE GROUP ACQUIRES OUTCOMES'10, EXPANDING EUROPEAN MARKET ACCESS CAPABILITIES

From Molecule to Market and Beyond: Uniphar Announces Extended Global Commercialization Platform

The 2nd Boao International Conference on Real World Studies of Medical Products Held in Hainan